close

Clinical Trials

1 208 209 210 211 212 220
Number of results: 4389

PDF print is not allowed for data more than 300.Please search above for fewer data.

Date Product Disease Phase Company Therapeutic area
2011-09-07 VRP700

chronic intractable cough due to underlying lung disease

Verona Pharma (UK) Respiratory diseases - Lung diseases
2011-09-06 lexapeptid pegol (NOX-H94)

anemia of chronic diseases as infections, cancers, autoimmune diseases and chronic kidney disease

1 Noxxon Pharma (Germany) Infectious diseases - Hematological diseases - Cancer - Oncology - Autoimmune diseases - Kidney diseases
2011-09-06 resminostat (oral pan-histone deacetylase (HDAC) inhibitor) relapsed/refractory Hodgkin's Lymphoma 2 4SC (Germany) Cancer - Oncology
2011-09-06 AIC316 genital herpes 2 AiCuris (Germany) Infectious diseases
2011-09-05 ICES13 stress urinary incontinence 2b Innovacell (Austria)
2011-09-01 maytansinoid-conjugated human monoclonal antibody against mesothelin (BAY 94-9343 - antibody drug conjugate ADC))

advanced solid tumors

1 Bayer (Germany) Cancer - Oncology
2011-08-29 Solulin (recombinant human thrombomodulin) hemophilia A 1b Paion (Germany) Hematological diseases - Genetic diseases - Rare diseases
2011-08-29 macitentan idiopathic pulmonary fibrosis 2 Actelion (Switzerland) Respiratory diseases - Lung diseases
2011-08-23 PNB01 major depression disorder (MDD) 3 PharmaNeuroBoost (Belgium) Mental diseases - CNS diseases
2011-08-23 somatic cell therapy advanced peripheral arterial occlusive disease (pAOD) after angioplasty 1-2 apceth (Germany) Cardiovascular diseases
2011-08-23 Sym004

metastatic squamous cell carcinoma of the head and neck

2 Symphogen (Denmark) Cancer Oncology
2011-08-17 RPL554 mild asthma Verona Pharma (UK) Allergic diseases - Inflammatory diseases - Respiratory diseases
2011-08-17 RPL554 mild asthma Verona Pharma (UK) Allergic diseases - Inflammatory diseases - Respiratory diseases
2011-08-17 KUR-023 adjunction to normal closure techniques such as suturing Kuros (Switzerland)
2011-08-16 COR-1 heart failure, dilated cardiomyopathy (DCM) 2 Corimmune (Germany), Cluster m4 personalised medicine and targeted therapies (Germany) Cardiovascular diseases
2011-08-15 IPX066 (investigational carbidopa-levodopa (CD-LD) product with an enhanced pharmacokinetic profile)

Parkinson’s disease

3 GSK (UK) Impax Pharmaceuticals (USA - CA) Neurodegenerative diseases - CNS diseases
2011-08-05 ofatumumab diffuse large B-cell lymphoma 2 Genmab (Denmark) Cancer Oncology
2011-08-04 lebrikizumab asthma 2 Roche (Switzerland) Allergic diseases - Inflammatory diseases - Respiratory diseases
2011-08-03 colon cancer screening tests colorectal advanced adenomatous polyps MDX Health (Belgium) Exact Sciences (USA) Cancer Oncology
2011-08-02 ponesimod relapsing-remitting multiple sclerosis 2b Actelion (Switzerland) Autoimmune diseases - Neurodegenerative diseases